Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1469) 1469
male (1377) 1377
hyperlipidemias - chemically induced (1349) 1349
science & technology (1303) 1303
life sciences & biomedicine (1257) 1257
animals (992) 992
female (840) 840
hyperlipidemias - drug therapy (624) 624
rats (555) 555
hyperlipidemia (543) 543
adult (531) 531
biological and medical sciences (528) 528
middle aged (528) 528
triglycerides - blood (503) 503
medical sciences (494) 494
cholesterol - blood (395) 395
hyperlipidemias - blood (348) 348
lipids - blood (326) 326
risk factors (317) 317
pharmacology & pharmacy (310) 310
pharmacology. drug treatments (309) 309
abridged index medicus (259) 259
aged (259) 259
hyperlipidemias - metabolism (245) 245
hyperlipidemias - complications (243) 243
mice (219) 219
hiv infections - drug therapy (209) 209
liver - metabolism (205) 205
lipids (198) 198
cholesterol (197) 197
hypolipidemic agents - therapeutic use (181) 181
disease models, animal (179) 179
liver - drug effects (165) 165
rats, wistar (157) 157
cardiovascular system & cardiology (152) 152
lipid metabolism (146) 146
lipoproteins - blood (138) 138
insulin resistance (137) 137
time factors (135) 135
hiv protease inhibitors - adverse effects (132) 132
hypolipidemic agents - pharmacology (131) 131
triglycerides (131) 131
atherosclerosis (130) 130
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (129) 129
drug toxicity and drugs side effects treatment (126) 126
diabetes (124) 124
dose-response relationship, drug (124) 124
rats, sprague-dawley (120) 120
hyperlipidemias - prevention & control (119) 119
biochemistry & molecular biology (117) 117
rabbits (114) 114
antipsychotic agents - adverse effects (111) 111
cardiac & cardiovascular systems (111) 111
cholesterol, ldl - blood (111) 111
hypolipidemic agents - adverse effects (107) 107
drug therapy, combination (106) 106
adolescent (104) 104
general & internal medicine (104) 104
infectious diseases (104) 104
research (104) 104
rodents (102) 102
hyperlipidemias - epidemiology (100) 100
treatment outcome (100) 100
drug therapy (99) 99
hyperlipidemias - etiology (99) 99
diabetes mellitus (97) 97
diet (97) 97
hyperlipidemias - pathology (96) 96
cholesterol, hdl - blood (95) 95
hyperlipidemias - genetics (93) 93
endocrinology & metabolism (92) 92
health aspects (92) 92
retrospective studies (91) 91
rhabdomyolysis - chemically induced (91) 91
medicine, general & internal (90) 90
metabolic diseases (90) 90
immunology (89) 89
blood glucose - metabolism (88) 88
drug interactions (88) 88
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (86) 86
statins (86) 86
aids/hiv (85) 85
fatty acids, nonesterified - blood (85) 85
diabetes mellitus - chemically induced (84) 84
lipoproteins (84) 84
antiretroviral therapy, highly active - adverse effects (83) 83
body weight (82) 82
liver (82) 82
plant extracts - pharmacology (82) 82
cardiovascular disease (81) 81
hyperlipidemias - physiopathology (81) 81
care and treatment (80) 80
anti-hiv agents - adverse effects (78) 78
mice, inbred c57bl (78) 78
miscellaneous (78) 78
psychiatry (78) 78
toxicology (78) 78
muscular diseases - chemically induced (77) 77
physiological aspects (76) 76
antipsychotic agents - therapeutic use (75) 75
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2038) 2038
French (86) 86
German (75) 75
Japanese (52) 52
Russian (38) 38
Spanish (31) 31
Polish (22) 22
Italian (15) 15
Chinese (10) 10
Hebrew (5) 5
Dutch (4) 4
Portuguese (4) 4
Romanian (4) 4
Swedish (4) 4
Norwegian (3) 3
Bulgarian (2) 2
Finnish (2) 2
Ukrainian (2) 2
Croatian (1) 1
Danish (1) 1
Hungarian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Understanding, recognizing, and managing toxicities of targeted anticancer therapies
by Dy, Grace K and Adjei, Alex A
CA: a cancer journal for clinicians, ISSN 0007-9235, 07/2013, Volume 63, Issue 4, pp. 249 - 279
toxicity | kinase inhibitors | therapeutic index | targeted agents | mechanism‐based toxicity | immunotherapeutic agents | off‐target toxicity | mechanism-based toxicity | off-target toxicity | Life Sciences & Biomedicine | Oncology | Science & Technology | Mood Disorders - chemically induced | Drug Eruptions - etiology | Peripheral Nervous System Diseases - chemically induced | Bone Marrow Diseases - chemically induced | Cachexia - chemically induced | Endocrine System Diseases - chemically induced | Pleural Effusion - chemically induced | Humans | Drug Eruptions - therapy | Immune System Diseases - chemically induced | Lung Diseases, Interstitial - chemically induced | Thrombocytopenia - chemically induced | Diarrhea - chemically induced | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Hyperbilirubinemia - chemically induced | Venous Thromboembolism - chemically induced | Vision Disorders - chemically induced | Hemorrhage - chemically induced | Heart Diseases - chemically induced | Hyperlipidemias - chemically induced | Magnesium - blood | Antimitotic agents | Drugs | Prevention | Complications and side effects | Drug targeting | Antineoplastic agents | Health aspects | Risk factors | Proteins | Side effects | Genomics | Cytotoxicity | Molecular biology | Cancer therapies | Cells | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Statin-Associated Side Effects
by Thompson, Paul D., MD and Panza, Gregory, MS and Zaleski, Amanda, MS and Taylor, Beth, PhD
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 20, pp. 2395 - 2410
Cardiovascular | Internal Medicine | rhabdomyolysis | skeletal muscle | interstitial lung disease | myopathy | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Liver Function Tests | Sleep Wake Disorders - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - immunology | Myalgia - chemically induced | Humans | Hyperlipidemias - drug therapy | Risk Factors | Lung Diseases, Interstitial - chemically induced | Tendon Injuries - chemically induced | Necrosis - chemically induced | Brain - drug effects | Rupture - chemically induced | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Stroke - chemically induced | Cognition Disorders - etiology | Depression - chemically induced | Rhabdomyolysis - chemically induced | Antibodies - blood | Diabetes Mellitus - chemically induced | Acute Kidney Injury - chemically induced | Muscular Diseases - chemically induced | Testosterone - blood | Autoimmune Diseases - chemically induced | Hyperlipidemias - complications | Viral antibodies | Complications and side effects | Enzymes | Thiols | Antibodies | Diabetes | Cardiology | Statins | Cardiovascular agents | Creatine kinase | Muscles | Creatine | Respiratory tract diseases | Studies | Musculoskeletal system | Genotype & phenotype | Mortality | Clinical trials | Lipids | Clinical medicine | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Physical Health Monitoring of Patients With Schizophrenia
by Marder, Stephen R and Essock, Susan M and Miller, Alexander L and Buchanan, Robert W and Casey, Daniel E and Davis, John M and Kane, John M and Lieberman, Jeffrey A and Schooler, Nina R and Covell, Nancy and Stroup, Scott and Weissman, Ellen M and Wirshing, Donna A and Hall, Catherine S and Pogach, Leonard and Pi-Sunyer, Xavier and Bigger, J. Thomas and Friedman, Alan and Kleinberg, David and Yevich, Steven J and Davis, Bonnie and Shon, Steven
The American journal of psychiatry, ISSN 0002-953X, 08/2004, Volume 161, Issue 8, pp. 1334 - 1349
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Biological and medical sciences | Medical sciences | Drug toxicity and drugs side effects treatment | Miscellaneous (drug allergy, mutagens, teratogens...) | Pharmacology. Drug treatments | Clozapine - therapeutic use | Myocarditis - chemically induced | Cataract - chemically induced | Antipsychotic Agents - adverse effects | Humans | Long QT Syndrome - chemically induced | Sexual Dysfunctions, Psychological - chemically induced | Myocarditis - diagnosis | Hyperlipidemias - diagnosis | Sexual Dysfunctions, Psychological - diagnosis | Long QT Syndrome - diagnosis | Schizophrenia - diagnosis | Antipsychotic Agents - therapeutic use | Hyperprolactinemia - diagnosis | Basal Ganglia Diseases - diagnosis | Adult | Obesity - diagnosis | Weight Gain | Basal Ganglia Diseases - chemically induced | Cataract - diagnosis | Hyperprolactinemia - chemically induced | Diabetes Mellitus, Type 2 - diagnosis | Monitoring, Physiologic - methods | Diabetes Mellitus, Type 2 - chemically induced | Schizophrenia - drug therapy | Clozapine - adverse effects | Health Status | Hyperlipidemias - chemically induced | Practice Guidelines as Topic | Schizophrenia | Research | Physical fitness | Primary care | Medical treatment | Mental health | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit
by Devlin, John W and Mallow-Corbett, Stephanie and Riker, Richard R
Critical care medicine, ISSN 0090-3493, 06/2010, Volume 38 Suppl, Identification and Prevention of Common Adverse Drug Events in the Intensive Care Unit, Issue 6, pp. S231 - S243
Coma | Delirium | Dverse drug events | Benzodiazepine | Critical care | Fentanyl | Opioid | Pharmacology | Haloperidol | Drug safety | Intensive care unit | Prevention | Analgesic | Dexmedetomidine | Antipsychotic | Lorazepam | Midazolam | Propofol | Sedative | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Critical Care - methods | Drug-Related Side Effects and Adverse Reactions - prevention & control | Hypnotics and Sedatives - adverse effects | Drug-Related Side Effects and Adverse Reactions - chemically induced | Endocrine System Diseases - chemically induced | United States | Antipsychotic Agents - adverse effects | Humans | Excipients - adverse effects | Fatty Liver - chemically induced | Infection - etiology | Muscular Diseases - chemically induced | Propofol - administration & dosage | Analgesics - adverse effects | Intensive Care Units | Infection - immunology | Acidosis - chemically induced | Substance Withdrawal Syndrome | Syndrome | Bradycardia - chemically induced | Immune System - drug effects | Nervous System Diseases - chemically induced | Cardiovascular Diseases - chemically induced | Infusions, Intravenous | Hyperlipidemias - chemically induced | Drug-Related Side Effects and Adverse Reactions - physiopathology | Gastrointestinal Diseases - chemically induced | Propofol - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights